Isomorphic Labs is an AI-driven company specializing in drug design and development. The company leverages advanced artificial intelligence research to enhance its drug design engine and expand its pipeline of drug candidates.
Estimated Valuation
Powered by
Leadership & Board
Key Executives
- Chief Executive Officer
- Demis Hassabis
- Chief Medical Officer
- Beni Wolf
- Chief Technology Officer
- Sergei Yakneen
- Current Number of Employees
- 456
- Current LinkedIn Followers
- 112,060
Latest Estimated Valuation
- Total Amount Raised
- $3B
- Total Funding Rounds
- 2
- Latest Funding Amount
- $2B
- Latest Funding Round
- Series B
Employee Trend
Isomorphic Labs had 456 employees as of October 26, 2026. The number of employees increased by 0 (0.00%) week-over-week.
456Latest Employee Count
0(0.00%)Week-Over-Week Change
Social Trend
Isomorphic Labs had 112,060 followers as of October 26, 2026. The number of followers increased by 835 (0.75%) week-over-week.
112,060Latest Followers Count
835(0.75%)Week-Over-Week Change
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Aug 20, 2026 | Series B | $2.10B | ― |
| Mar 31, 2025 | Series A | $600.00M | ― |
Investors
| Investor Name | Funding Round |
|---|---|
| Thrive Capital | Series B |
| Alphabet | Series B |
| GV | Series B |
| MGX | Series B |
| Temasek | Series B |
| CapitalG | Series B |
| UK Sovereign AI Fund | Series B |
| GV | Series A |
Similar Companies
A snapshot of private companies similar to Isomorphic Labs, helping you discover and navigate related company profiles.
Related News and Analysis
